We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Counters FDA’s Decision To Warn for Blockbuster Plavix
Study Counters FDA’s Decision To Warn for Blockbuster Plavix
January 6, 2012
A boxed warning recommending patients receive a genetic test before taking blockbuster blood-thinner Plavix may be unnecessary, according to a review of 32 studies of the drug.